← All Sponsors
SPONSOR

Herui Yao

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Metastatic Breast Cancer
NCT04263298 Phase 3
Recruiting

Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer

Metastatic Breast Cancer
China View Trial →